Irish manufacturing production has grown for a second consecutive quarter, with the Central Statistics Office’s Industrial Production and Turnover Indices for July 2026, released on 9 September, recording a 2.7% quarterly rise in production and a 2.5% quarterly advance in turnover across the May-to-July period. For senior leaders across Irish industrial manufacturing, back-to-back quarters of production growth signal a sustained shift in momentum.

Three aspects of the July data carry direct strategic implications for manufacturing Ireland: the strengthening trajectory of rolling quarterly production growth, now spanning two consecutive positive periods; the full recovery of annual turnover to flat, confirming commercial performance has matched the prior year’s level; and the narrowing annual production gap, which reflects normalisation from an exceptional 2025 base rather than structural weakness in the sector.

The consecutive quarterly production gains represent the most compelling narrative in the data. The preceding release showed production growing 4.5% quarterly in April-to-June, making the 2.7% gain in May-to-July the second successive positive reading. The annual turnover position is equally striking: from a decline of 7.2% in the prior release, annual turnover has recovered to 0%, erasing the year-on-year shortfall in a single reporting period.

Annual production declined 4.1% in the May-to-July period, an improvement on the 5.0% annual decline in the preceding quarter. The Modern sector, covering chemicals, pharmaceuticals, and computer and electronic products, saw an annual production decline of 4.4%, while the Traditional sector declined 3.5%. The CSO notes that contract manufacturing and outsourcing activity has grown significantly since 2015, introducing volatility that warrants a longer analytical horizon.

Context is essential here. In the same May-to-July period in 2025, manufacturing turnover fell 23.3% quarterly as pharmaceutical production unwound its tariff-driven stockpiling surge, creating a depressed comparative base. This is why the 2026 flat annual turnover result is particularly significant. The AIB Manufacturing PMI for August 2026 recorded 55.4, confirming real-time demand conditions across Irish manufacturing remain strongly expansionary and well above European peers.

Three actions stand out for Irish manufacturing leaders. First, embed rolling quarterly production trends as the primary strategic planning metric, aligning with the CSO’s longer-term view recommendation. Second, invest in production capacity and technology to sustain the consecutive quarterly growth trajectory. Third, accelerate export market development beyond established traditional partners, building on Ireland’s strong PMI performance to capture an expanding share of global manufacturing demand.

The July 2026 CSO data add further weight to a clear and positive trend: Irish manufacturing production is strengthening on a rolling quarterly basis while commercial performance is recovering strongly. For C-suite leaders committed to manufacturing excellence, two consecutive quarters of production growth and a fully recovered annual turnover position provide a compelling foundation to invest with confidence in the period ahead.